25 XP   0   0   10

Argen-X
Buy, Hold or Sell?

Let's analyse Argen-X together

PenkeI guess you are interested in Argen-X. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Argen-X. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Argen-X

I send you an email if I find something interesting about Argen-X.

Quick analysis of Argen-X (30 sec.)










What can you expect buying and holding a share of Argen-X? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€58.75
Expected worth in 1 year
€115.50
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
€56.74
Return On Investment
16.6%

For what price can you sell your share?

Current Price per Share
€342.00
Expected price per share
€271.00 - €412.20
How sure are you?
50%

1. Valuation of Argen-X (5 min.)




Live pricePrice per Share (EOD)

€342.00

Intrinsic Value Per Share

€-112.13 - €-12.75

Total Value Per Share

€-53.38 - €46.01

2. Growth of Argen-X (5 min.)




Is Argen-X growing?

Current yearPrevious yearGrowGrow %
How rich?$3.7b$2.8b$895.6m24.1%

How much money is Argen-X making?

Current yearPrevious yearGrowGrow %
Making money-$272.9m-$709.5m$436.6m160.0%
Net Profit Margin-24.1%-172.8%--

How much money comes from the company's main activities?

3. Financial Health of Argen-X (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#22 / 1016

Most Revenue
#16 / 1016

Most Profit
#1012 / 1016

Most Efficient
#505 / 1016

What can you expect buying and holding a share of Argen-X? (5 min.)

Welcome investor! Argen-X's management wants to use your money to grow the business. In return you get a share of Argen-X.

What can you expect buying and holding a share of Argen-X?

First you should know what it really means to hold a share of Argen-X. And how you can make/lose money.

Speculation

The Price per Share of Argen-X is €342.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Argen-X.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Argen-X, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €58.75. Based on the TTM, the Book Value Change Per Share is €14.19 per quarter. Based on the YOY, the Book Value Change Per Share is €4.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Argen-X.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-4.60-1.3%-4.60-1.3%-11.97-3.5%-7.35-2.2%-3.92-1.1%
Usd Book Value Change Per Share15.104.4%15.104.4%4.711.4%10.433.1%6.201.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share15.104.4%15.104.4%4.711.4%10.433.1%6.201.8%
Usd Price Per Share365.69-365.69-370.80-296.53-166.62-
Price to Earnings Ratio-79.46--79.46--30.99--46.87--57.29-
Price-to-Total Gains Ratio24.21-24.21-78.68-34.56-22.84-
Price to Book Ratio5.85-5.85-7.82-7.66-9.53-
Price-to-Total Gains Ratio24.21-24.21-78.68-34.56-22.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share364.0932
Number of shares2
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share15.1010.43
Usd Total Gains Per Share15.1010.43
Gains per Quarter (2 shares)30.2020.87
Gains per Year (2 shares)120.8283.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1012111108373
202422320167156
303623530250239
404834740334322
506045950417405
607257160501488
708468370584571
809679580668654
90108710790751737
100120812000835820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.02.00.084.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.02.00.084.6%

Fundamentals of Argen-X

About Argen-X

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

Fundamental data was last updated by Penke on 2024-04-09 20:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Argen-X.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Argen-X earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • A Net Profit Margin of -24.1% means that €-0.24 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Argen-X:

  • The MRQ is -24.1%. The company is making a huge loss. -2
  • The TTM is -24.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-24.1%TTM-24.1%0.0%
TTM-24.1%YOY-172.8%+148.7%
TTM-24.1%5Y-392.9%+368.8%
5Y-392.9%10Y-299.5%-93.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.1%-197.2%+173.1%
TTM-24.1%-210.4%+186.3%
YOY-172.8%-279.3%+106.5%
5Y-392.9%-436.8%+43.9%
10Y-299.5%-599.3%+299.8%
1.1.2. Return on Assets

Shows how efficient Argen-X is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • -6.6% Return on Assets means that Argen-X generated €-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Argen-X:

  • The MRQ is -6.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.6%TTM-6.6%0.0%
TTM-6.6%YOY-22.6%+16.0%
TTM-6.6%5Y-16.7%+10.1%
5Y-16.7%10Y-17.4%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.6%-13.6%+7.0%
TTM-6.6%-12.9%+6.3%
YOY-22.6%-11.9%-10.7%
5Y-16.7%-14.2%-2.5%
10Y-17.4%-16.2%-1.2%
1.1.3. Return on Equity

Shows how efficient Argen-X is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • -7.4% Return on Equity means Argen-X generated €-0.07 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Argen-X:

  • The MRQ is -7.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.4%TTM-7.4%0.0%
TTM-7.4%YOY-25.2%+17.9%
TTM-7.4%5Y-20.6%+13.2%
5Y-20.6%10Y-21.9%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.4%-17.0%+9.6%
TTM-7.4%-16.1%+8.7%
YOY-25.2%-15.4%-9.8%
5Y-20.6%-20.0%-0.6%
10Y-21.9%-21.1%-0.8%

1.2. Operating Efficiency of Argen-X.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Argen-X is operating .

  • Measures how much profit Argen-X makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • An Operating Margin of -36.8% means the company generated €-0.37  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Argen-X:

  • The MRQ is -36.8%. The company is operating very inefficient. -2
  • The TTM is -36.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-36.8%TTM-36.8%0.0%
TTM-36.8%YOY-175.2%+138.4%
TTM-36.8%5Y-337.0%+300.2%
5Y-337.0%10Y-270.2%-66.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.8%-286.1%+249.3%
TTM-36.8%-224.4%+187.6%
YOY-175.2%-288.4%+113.2%
5Y-337.0%-475.2%+138.2%
10Y-270.2%-624.7%+354.5%
1.2.2. Operating Ratio

Measures how efficient Argen-X is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are €1.37 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Argen-X:

  • The MRQ is 1.368. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.368. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.368TTM1.3680.000
TTM1.368YOY2.752-1.384
TTM1.3685Y4.893-3.525
5Y4.89310Y5.261-0.369
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3682.997-1.629
TTM1.3683.247-1.879
YOY2.7523.766-1.014
5Y4.8935.675-0.782
10Y5.2617.857-2.596

1.3. Liquidity of Argen-X.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Argen-X is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.75 means the company has €9.75 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Argen-X:

  • The MRQ is 9.749. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.749. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.749TTM9.7490.000
TTM9.749YOY9.178+0.571
TTM9.7495Y8.443+1.306
5Y8.44310Y8.493-0.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7493.930+5.819
TTM9.7494.251+5.498
YOY9.1785.436+3.742
5Y8.4436.045+2.398
10Y8.4936.363+2.130
1.3.2. Quick Ratio

Measures if Argen-X is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • A Quick Ratio of 11.37 means the company can pay off €11.37 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Argen-X:

  • The MRQ is 11.372. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.372. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.372TTM11.3720.000
TTM11.372YOY12.775-1.404
TTM11.3725Y11.728-0.356
5Y11.72810Y11.831-0.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3723.629+7.743
TTM11.3724.065+7.307
YOY12.7755.397+7.378
5Y11.7285.993+5.735
10Y11.8316.277+5.554

1.4. Solvency of Argen-X.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Argen-X assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Argen-X to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Argen-X assets are financed with 9.8% credit (debt) and the remaining percentage (100% - 9.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Argen-X:

  • The MRQ is 0.098. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.098. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.098TTM0.0980.000
TTM0.098YOY0.102-0.004
TTM0.0985Y0.169-0.071
5Y0.16910Y0.172-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0980.332-0.234
TTM0.0980.334-0.236
YOY0.1020.268-0.166
5Y0.1690.366-0.197
10Y0.1720.390-0.218
1.4.2. Debt to Equity Ratio

Measures if Argen-X is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.9% means that company has €0.11 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Argen-X:

  • The MRQ is 0.109. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.109. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.109TTM0.1090.000
TTM0.109YOY0.114-0.005
TTM0.1095Y0.215-0.106
5Y0.21510Y0.229-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1090.381-0.272
TTM0.1090.390-0.281
YOY0.1140.334-0.220
5Y0.2150.434-0.219
10Y0.2290.466-0.237

2. Market Valuation of Argen-X

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Argen-X generates.

  • Above 15 is considered overpriced but always compare Argen-X to the Biotechnology industry mean.
  • A PE ratio of -79.46 means the investor is paying €-79.46 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Argen-X:

  • The EOD is -79.116. Based on the earnings, the company is expensive. -2
  • The MRQ is -79.463. Based on the earnings, the company is expensive. -2
  • The TTM is -79.463. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-79.116MRQ-79.463+0.347
MRQ-79.463TTM-79.4630.000
TTM-79.463YOY-30.989-48.474
TTM-79.4635Y-46.870-32.593
5Y-46.87010Y-57.287+10.417
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-79.116-2.315-76.801
MRQ-79.463-2.560-76.903
TTM-79.463-2.664-76.799
YOY-30.989-4.122-26.867
5Y-46.870-6.258-40.612
10Y-57.287-6.108-51.179
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Argen-X:

  • The EOD is -62.855. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -63.131. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -63.131. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-62.855MRQ-63.131+0.276
MRQ-63.131TTM-63.1310.000
TTM-63.131YOY-22.749-40.382
TTM-63.1315Y-12.289-50.842
5Y-12.28910Y-24.275+11.986
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-62.855-3.067-59.788
MRQ-63.131-3.251-59.880
TTM-63.131-3.545-59.586
YOY-22.749-5.595-17.154
5Y-12.289-8.315-3.974
10Y-24.275-8.708-15.567
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Argen-X is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.85 means the investor is paying €5.85 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Argen-X:

  • The EOD is 5.821. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.847. Based on the equity, the company is overpriced. -1
  • The TTM is 5.847. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.821MRQ5.847-0.026
MRQ5.847TTM5.8470.000
TTM5.847YOY7.815-1.969
TTM5.8475Y7.665-1.818
5Y7.66510Y9.534-1.869
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.8211.905+3.916
MRQ5.8472.111+3.736
TTM5.8472.095+3.752
YOY7.8152.836+4.979
5Y7.6653.443+4.222
10Y9.5343.794+5.740
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Argen-X compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.18614.1860%4.427+220%9.800+45%5.828+143%
Book Value Per Share--58.75358.7530%44.567+32%37.737+56%20.766+183%
Current Ratio--9.7499.7490%9.178+6%8.443+15%8.493+15%
Debt To Asset Ratio--0.0980.0980%0.102-4%0.169-42%0.172-43%
Debt To Equity Ratio--0.1090.1090%0.114-5%0.215-49%0.229-53%
Dividend Per Share----0%-0%-0%-0%
Eps---4.323-4.3230%-11.239+160%-6.907+60%-3.678-15%
Free Cash Flow Per Share---5.441-5.4410%-15.311+181%-7.495+38%-3.935-28%
Free Cash Flow To Equity Per Share--14.14314.1430%-1.946+114%7.901+79%4.934+187%
Gross Profit Margin--1.7411.7410%1.003+74%1.191+46%1.098+58%
Intrinsic Value_10Y_max---12.746--------
Intrinsic Value_10Y_min---112.131--------
Intrinsic Value_1Y_max---3.370--------
Intrinsic Value_1Y_min---10.993--------
Intrinsic Value_3Y_max---8.530--------
Intrinsic Value_3Y_min---33.436--------
Intrinsic Value_5Y_max---11.767--------
Intrinsic Value_5Y_min---56.153--------
Market Cap20281352400.0000%20370305700.00020370305700.0000%20654956260.000-1%16518034788.000+23%9281565228.600+119%
Net Profit Margin---0.241-0.2410%-1.728+618%-3.929+1533%-2.995+1145%
Operating Margin---0.368-0.3680%-1.752+376%-3.370+816%-2.702+635%
Operating Ratio--1.3681.3680%2.752-50%4.893-72%5.261-74%
Pb Ratio5.8210%5.8475.8470%7.815-25%7.665-24%9.534-39%
Pe Ratio-79.116+0%-79.463-79.4630%-30.989-61%-46.870-41%-57.287-28%
Price Per Share342.0000%343.500343.5000%348.300-1%278.540+23%156.513+119%
Price To Free Cash Flow Ratio-62.855+0%-63.131-63.1310%-22.749-64%-12.289-81%-24.275-62%
Price To Total Gains Ratio24.1080%24.21424.2140%78.682-69%34.559-30%22.844+6%
Quick Ratio--11.37211.3720%12.775-11%11.728-3%11.831-4%
Return On Assets---0.066-0.0660%-0.226+241%-0.167+151%-0.174+162%
Return On Equity---0.074-0.0740%-0.252+243%-0.206+180%-0.219+197%
Total Gains Per Share--14.18614.1860%4.427+220%9.800+45%5.828+143%
Usd Book Value--3709247319.1023709247319.1020%2813640293.286+32%2382425313.462+56%1311009437.810+183%
Usd Book Value Change Per Share--15.10215.1020%4.713+220%10.433+45%6.204+143%
Usd Book Value Per Share--62.54862.5480%47.446+32%40.174+56%22.107+183%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---4.602-4.6020%-11.965+160%-7.353+60%-3.916-15%
Usd Free Cash Flow---343513789.483-343513789.4830%-966609488.111+181%-473164355.727+38%-248430168.176-28%
Usd Free Cash Flow Per Share---5.793-5.7930%-16.300+181%-7.979+38%-4.189-28%
Usd Free Cash Flow To Equity Per Share--15.05715.0570%-2.072+114%8.411+79%5.253+187%
Usd Market Cap21591527765.0400%21686227448.22021686227448.2200%21989266434.396-1%17585099835.305+23%9881154342.368+119%
Usd Price Per Share364.0930%365.690365.6900%370.800-1%296.534+23%166.624+119%
Usd Profit---272909518.737-272909518.7370%-709578942.415+160%-444765149.473+63%-238549767.326-13%
Usd Revenue--1134282008.0251134282008.0250%410737283.970+176%433050617.871+162%226104607.038+402%
Usd Total Gains Per Share--15.10215.1020%4.713+220%10.433+45%6.204+143%
 EOD+2 -6MRQTTM+0 -0YOY+29 -55Y+31 -310Y+26 -8

3.2. Fundamental Score

Let's check the fundamental score of Argen-X based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-79.116
Price to Book Ratio (EOD)Between0-15.821
Net Profit Margin (MRQ)Greater than0-0.241
Operating Margin (MRQ)Greater than0-0.368
Quick Ratio (MRQ)Greater than111.372
Current Ratio (MRQ)Greater than19.749
Debt to Asset Ratio (MRQ)Less than10.098
Debt to Equity Ratio (MRQ)Less than10.109
Return on Equity (MRQ)Greater than0.15-0.074
Return on Assets (MRQ)Greater than0.05-0.066
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Argen-X based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.430
Ma 20Greater thanMa 50357.210
Ma 50Greater thanMa 100358.860
Ma 100Greater thanMa 200366.371
OpenGreater thanClose341.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,112,124
Total Liabilities402,798
Total Stockholder Equity3,709,326
 As reported
Total Liabilities 402,798
Total Stockholder Equity+ 3,709,326
Total Assets = 4,112,124

Assets

Total Assets4,112,124
Total Current Assets3,733,071
Long-term Assets379,053
Total Current Assets
Cash And Cash Equivalents 1,854,745
Short-term Investments 1,023,854
Net Receivables 451,972
Inventory 281,130
Other Current Assets 121,371
Total Current Assets  (as reported)3,733,071
Total Current Assets  (calculated)3,733,071
+/- 0
Long-term Assets
Property Plant Equipment 20,527
Long Term Investments 47,155
Intangible Assets 125,228
Long-term Assets Other 30,980
Long-term Assets  (as reported)379,053
Long-term Assets  (calculated)223,890
+/- 155,163

Liabilities & Shareholders' Equity

Total Current Liabilities382,920
Long-term Liabilities19,878
Total Stockholder Equity3,709,326
Total Current Liabilities
Short-term Debt 4,206
Accounts payable 222,294
Other Current Liabilities 152,497
Total Current Liabilities  (as reported)382,920
Total Current Liabilities  (calculated)378,997
+/- 3,923
Long-term Liabilities
Capital Lease Obligations 20,000
Long-term Liabilities  (as reported)19,878
Long-term Liabilities  (calculated)20,000
+/- 122
Total Stockholder Equity
Common Stock6,389
Retained Earnings -2,177,019
Accumulated Other Comprehensive Income 763,858
Other Stockholders Equity 4,477,710
Total Stockholder Equity (as reported)3,709,326
Total Stockholder Equity (calculated)3,070,938
+/- 638,388
Other
Capital Stock7,058
Cash and Short Term Investments 2,878,599
Common Stock Shares Outstanding 57,169
Current Deferred Revenue3,923
Liabilities and Stockholders Equity 4,112,124
Net Debt -1,836,640
Net Invested Capital 4,097,507
Net Working Capital 3,700,744
Property Plant and Equipment Gross 45,351
Short Long Term Debt Total 18,105



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
12,261
31,941
22,930
34,540
71,149
50,250
111,241
444,979
661,700
1,605,586
2,284,873
2,850,274
3,134,261
4,112,124
4,112,1243,134,2612,850,2742,284,8731,605,586661,700444,979111,24150,25071,14934,54022,93031,94112,261
   > Total Current Assets 
11,892
31,569
22,479
33,731
69,771
48,255
107,056
440,056
654,819
1,538,242
2,061,782
2,542,971
2,774,197
3,733,071
3,733,0712,774,1972,542,9712,061,7821,538,242654,819440,056107,05648,25569,77133,73122,47931,56911,892
       Cash And Cash Equivalents 
10,501
30,515
20,406
31,373
39,131
38,828
94,545
228,984
321,482
371,093
1,219,631
1,334,676
800,740
1,854,745
1,854,745800,7401,334,6761,219,631371,093321,482228,98494,54538,82839,13131,37320,40630,51510,501
       Short-term Investments 
0
0
1,389
690
28,933
7,449
7,184
202,638
324,330
1,125,257
781,461
1,002,052
1,391,808
1,023,854
1,023,8541,391,8081,002,052781,4611,125,257324,330202,6387,1847,44928,9336901,38900
       Net Receivables 
1,386
986
569
1,519
1,593
1,483
2,243
3,599
3,646
31,786
7,458
38,221
277,275
451,972
451,972277,27538,2217,45831,7863,6463,5992,2431,4831,5931,5195699861,386
       Other Current Assets 
5
67
115
148
114
496
3,084
4,835
5,361
9,022
27,978
58,946
-1
121,371
121,371-158,94627,9789,0225,3614,8353,084496114148115675
   > Long-term Assets 
369
372
451
809
1,379
1,995
4,185
4,924
6,881
67,345
223,091
307,303
360,064
379,053
379,053360,064307,303223,09167,3456,8814,9244,1851,9951,379809451372369
       Property Plant Equipment 
328
356
233
166
202
272
806
811
943
9,148
11,677
15,843
16,235
20,527
20,52716,23515,84311,6779,148943811806272202166233356328
       Long Term Investments 
0
0
0
1
1
1
1
1
1
2,596
5,140
53,169
40,481
47,155
47,15540,48153,1695,1402,596111111000
       Intangible Assets 
41
16
0
0
9
8
18
16
64
44,987
167,778
171,684
174,901
125,228
125,228174,901171,684167,77844,98764161889001641
       Other Assets 
0
0
902
465
959
3,991
3,195
3,414
5,134
0
37,173
66,606
128,448
0
0128,44866,60637,17305,1343,4143,1953,99195946590200
> Total Liabilities 
2,029
4,043
6,278
4,568
10,249
9,494
44,590
31,165
45,828
428,570
606,760
316,050
320,561
402,798
402,798320,561316,050606,760428,57045,82831,16544,5909,49410,2494,5686,2784,0432,029
   > Total Current Liabilities 
2,029
4,043
6,278
4,569
10,249
9,494
44,589
31,135
45,820
179,179
329,257
301,239
302,277
382,920
382,920302,277301,239329,257179,17945,82031,13544,5899,49410,2494,5696,2784,0432,029
       Short-term Debt 
0
2,193
2,238
0
0
0
0
0
0
2,211
3,484
3,509
3,417
4,206
4,2063,4173,5093,4842,2110000002,2382,1930
       Accounts payable 
1,690
363
1,850
1,241
2,005
2,062
4,612
18,337
6,871
95,552
206,804
208,850
188,721
222,294
222,294188,721208,850206,80495,5526,87118,3374,6122,0622,0051,2411,8503631,690
       Other Current Liabilities 
0
1,487
1,620
2,698
4,047
2,905
8,210
716
35,535
385
72,533
88,880
110,139
152,497
152,497110,13988,88072,53338535,5357168,2102,9054,0472,6981,6201,4870
   > Long-term Liabilities 
0
0
0
-1
0
0
1
30
8
249,391
277,503
14,811
18,284
19,878
19,87818,28414,811277,503249,391830100-1000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
4,540
0
0
0
0
00004,540000000000
       Other Liabilities 
0
0
0
0
0
0
10,071
1,460
7
245,009
270,682
6,855
9,276
0
09,2766,855270,682245,00971,46010,071000000
> Total Stockholder Equity
10,232
27,898
16,652
29,972
60,900
40,756
66,651
413,815
615,872
1,177,016
1,678,113
2,534,224
2,813,700
3,709,326
3,709,3262,813,7002,534,2241,678,1131,177,016615,872413,81566,65140,75660,90029,97216,65227,89810,232
   Common Stock
248
439
448
643
1,910
1,727
2,116
3,859
4,115
4,790
5,851
6,233
6,640
6,389
6,3896,6406,2335,8514,7904,1153,8592,1161,7271,910643448439248
   Retained Earnings -2,177,019-2,109,791-1,400,197-1,059,592-372,533-194,009-120,652-76,240-55,887-43,541-35,200-25,604-12,523-8,410
   Accumulated Other Comprehensive Income 
297
540
1,562
1,969
2,890
5,081
7,884
14,113
35,400
78,971
200,462
465,413
606,971
763,858
763,858606,971465,413200,46278,97135,40014,1137,8845,0812,8901,9691,562540297
   Capital Surplus 
0
0
0
0
0
82,169
126,358
430,518
673,454
1,308,539
0
0
0
0
00001,308,539673,454430,518126,35882,16900000
   Treasury Stock00000000000000
   Other Stockholders Equity 
18,097
39,441
40,245
62,559
99,640
89,836
132,891
516,494
770,366
1,465,789
2,531,392
3,462,775
4,309,880
4,477,710
4,477,7104,309,8803,462,7752,531,3921,465,789770,366516,494132,89189,83699,64062,55940,24539,44118,097



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,134,306
Cost of Revenue-208,809
Gross Profit925,497925,497
 
Operating Income (+$)
Gross Profit925,497
Operating Expense-1,342,650
Operating Income-417,153-417,153
 
Operating Expense (+$)
Research Development697,378
Selling General Administrative507,393
Selling And Marketing Expenses202,146
Operating Expense1,342,6501,406,917
 
Net Interest Income (+$)
Interest Income78,079
Interest Expense-836
Other Finance Cost-933
Net Interest Income78,176
 
Pretax Income (+$)
Operating Income-417,153
Net Interest Income78,176
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-303,298-531,009
EBIT - interestExpense = -417,990
-307,378
-272,079
Interest Expense836
Earnings Before Interest and Taxes (EBIT)-417,153-302,462
Earnings Before Interest and Taxes (EBITDA)-314,198
 
After tax Income (+$)
Income Before Tax-303,298
Tax Provision--50,061
Net Income From Continuing Ops-234,497-253,237
Net Income-272,915
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,551,459
Total Other Income/Expenses Net113,856-78,176
 

Technical Analysis of Argen-X
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Argen-X. The general trend of Argen-X is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Argen-X's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Argen-X.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 378.30 < 381.10 < 412.20.

The bearish price targets are: 322.50 > 271.00.

Tweet this
Argen-X Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Argen-X. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Argen-X Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Argen-X. The current macd is -3.01970384.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Argen-X price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Argen-X. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Argen-X price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Argen-X Daily Moving Average Convergence/Divergence (MACD) ChartArgen-X Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Argen-X. The current adx is 15.56.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Argen-X shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Argen-X Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Argen-X. The current sar is 376.72.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Argen-X Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Argen-X. The current rsi is 40.43. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Argen-X Daily Relative Strength Index (RSI) ChartArgen-X Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Argen-X. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Argen-X price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Argen-X Daily Stochastic Oscillator ChartArgen-X Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Argen-X. The current cci is -138.67898125.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Argen-X Daily Commodity Channel Index (CCI) ChartArgen-X Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Argen-X. The current cmo is -28.31986923.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Argen-X Daily Chande Momentum Oscillator (CMO) ChartArgen-X Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Argen-X. The current willr is -80.32345013.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Argen-X Daily Williams %R ChartArgen-X Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Argen-X.

Argen-X Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Argen-X. The current atr is 10.04.

Argen-X Daily Average True Range (ATR) ChartArgen-X Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Argen-X. The current obv is -99,433.

Argen-X Daily On-Balance Volume (OBV) ChartArgen-X Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Argen-X. The current mfi is 17.98.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Argen-X Daily Money Flow Index (MFI) ChartArgen-X Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Argen-X.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Argen-X Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Argen-X based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.430
Ma 20Greater thanMa 50357.210
Ma 50Greater thanMa 100358.860
Ma 100Greater thanMa 200366.371
OpenGreater thanClose341.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Argen-X with someone you think should read this too:
  • Are you bullish or bearish on Argen-X? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Argen-X? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Argen-X

I send you an email if I find something interesting about Argen-X.


Comments

How you think about this?

Leave a comment

Stay informed about Argen-X.

Receive notifications about Argen-X in your mailbox!